Ipca Laboratories Limited

NSE:IPCALAB.NS

Location

Market Cap

USD 3.96 B

Share Price

USD 15.57

Avg Daily Volume

270,472

Change (1 day)

-0.18%

Change (1 year)

-3.00%

Change (YTD)

-21.37%

Ipca Laboratories Limited EBIT Margin for the year ending March 31, 2025: 13.60%

Ipca Laboratories Limited EBIT Margin is 13.60% for the year ending March 31, 2025, a 6.60% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Ipca Laboratories Limited EBIT Margin for the year ending March 31, 2024 was 12.76%, a 0.73% change year over year.
  • Ipca Laboratories Limited EBIT Margin for the year ending March 31, 2023 was 12.67%, a -36.25% change year over year.
  • Ipca Laboratories Limited EBIT Margin for the year ending March 31, 2022 was 19.87%, a -23.07% change year over year.
  • Ipca Laboratories Limited EBIT Margin for the year ending March 31, 2021 was 25.83%, a 56.02% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin